Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Journal of Ethnopharmacology|June 15, 2010
Anti-proliferative and anti-cancer properties of Achyranthes aspera: specific inhibitory activity against pancreatic cancer cellsPochi R Subbarayan, Malancha Sarkar, Stefania Impellizzeri, et al.Journal of Cancer Research and Clinical Oncology|March 6, 2003
Recombinant leukocyte interferon, doxorubicin, and 5FUDR in patients with hepatocellular carcinoma-A phase II trialLynn G Feun, Christopher O'Brien, Enrique Molina, et al.Japanese Journal of Clinical Oncology|January 25, 2011
A phase II study of neoadjuvant and adjuvant chemotherapy with 5-fluorodeoxyuridine, leucovorin, oxaliplatin and docetaxel in the treatment of previously untreated advanced esophageal adenocarcinomaNaveenraj Solomon, Dmitry Mezentsev, Isildinha Reis, et al.The Journal of Surgical Research|June 12, 2012
Does neoadjuvant chemotherapy improve outcomes for patients with gastric cancer?Subhasis Misra, Felipe E Pedroso, Peter J DiPasco, et al.Investigational New Drugs|August 5, 2004
A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: a Southwest Oncology Group studyRobert P Whitehead, Jacqueline K Benedetti, James L Abbruzzese, et al.Journal of Ethnopharmacology|May 30, 2012
Achyranthes aspera (Apamarg) leaf extract inhibits human pancreatic tumor growth in athymic mice by apoptosisPochi R Subbarayan, Malancha Sarkar, Shamaladevi Nagaraja Rao, et al.Annals of Surgical Oncology|March 5, 2013
Influence of treatment modality in outcomes for different stages of resectable esophageal adenocarcinomasBassan J Allan, Felipe Pedroso, Elisabeth R Gennis, et al.Investigational New Drugs|May 4, 2004
A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncology Group StudyRobert P Whitehead, Jacqueline K Benedetti, James L Abbruzzese, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2010
A phase I study of 5-fluorouracil/leucovorin and arsenic trioxide for patients with refractory/relapsed colorectal carcinomaBach Ardalan, Pochi R Subbarayan, Yipsel Ramos, et al.Japanese Journal of Clinical Oncology|August 21, 2007
Neoadjuvant, surgery and adjuvant chemotherapy without radiation for esophageal cancerBach Ardalan, Seth A Spector, Alan S Livingstone, et al.Pageof 4